SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001575705-22-000441
Filing Date
2022-06-17
Accepted
2022-06-17 10:59:29
Documents
14
Period of Report
2022-05-24
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A spk_8ka.htm   iXBRL 8-K/A 46386
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 114511
  Complete submission text file 0001575705-22-000441.txt   411005

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE spk-20220524.xsd EX-101.SCH 3387
4 XBRL DEFINITION FILE spk-20220524_def.xml EX-101.DEF 26850
5 XBRL LABEL FILE spk-20220524_lab.xml EX-101.LAB 36923
6 XBRL PRESENTATION FILE spk-20220524_pre.xml EX-101.PRE 25470
8 EXTRACTED XBRL INSTANCE DOCUMENT spk_8ka_htm.xml XML 6808
Mailing Address ROOM 368, 302 BUWEI 211 FUTE NORTH ROAD, SHANGHAI F4 200131
Business Address ROOM 368, 302 BUWEI 211 FUTE NORTH ROAD, SHANGHAI F4 200131 86 13439129879
SPK Acquisition Corp. (Filer) CIK: 0001848097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40462 | Film No.: 221022802
SIC: 2836 Biological Products, (No Diagnostic Substances)